The three-day event will include case studies on proactive initiatives and new technologies being used in drug safety. Over the three days, you will meet with over 200 high calibre potential customers who need to find solutions around pharmacovigilance systems, regulatory compliance and case management.
This is the event to discuss the latest issues facing the drug safety sector, including:
Some of the confirmed speakers include:
Sue Rees, EU QPPV, Executive Director, Global Safety, Grünenthal Gmbh
Peter De Veene, Senior VP & Head of Global Drug Safety and Qualified Person for Pharmacovigilance, GSK
Haris Shaikh, Director Safety Evaluation & Risk Management; Medical Director, Merck Serono
Berit Nautrup Andersen, QPPV Director & Head of Global Pharmacovigilance Support, Novo Nordisk
Betina Ostergaard Eriksen, Deputy QPPV, Novo Nordisk
Susan Welsh, Chief Safety Officer, Sanofi
There will be truly visionary keynotes, panel debates, quality networking breaks, chat show panels, speed networking and roundtable discussions throughout the event.
We will share with you thoughts from the pioneers in drug safety. You will hear from: